Rapid degradation of cyclooxygenase-1 and hematopoietic prostaglandin D synthase through ubiquitin-proteasome system in response to intracellular calcium level

Molecular Biology of the Cell

Volumn 23, Issue 1, 2012, Pages 12-21

  Yazaki, Misato ^a   Kashiwagi, Kaori ^b   Aritake, Kosuke ^b   Urade, Yoshihiro ^b   Fujimori, Ko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHLORIDE; CALCIUM ION; CYCLOOXYGENASE 1; EGTAZIC ACID; PROSTAGLANDIN D SYNTHASE; PROTEASOME; UBIQUITIN;

ARTICLE; CALCIUM CELL LEVEL; HALF LIFE TIME; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DEGRADATION; UBIQUITINATION;

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CALCIMYCIN; CALCIUM IONOPHORES; CALCIUM SIGNALING; CELL LINE; CYCLOOXYGENASE 1; HALF-LIFE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LEUPEPTINS; LIPOCALINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STABILITY; PROTEOLYSIS; UBIQUITINATED PROTEINS; UBIQUITINATION;

EID: 84855398969     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-07-0623     Document Type: Article

References (47)

1. Ardley HC, Robinson PA (2005). E3 ubiquitin ligases. Essays Biochem 41, 15-30. (Pubitemid 41500968)
2. Clague MJ, Urbe S (2010). Ubiquitin: same molecule, different degradation pathways. Cell 143, 682-685.
3. Dixon DA (2004). Dysregulated post-transcriptional control of COX-2 gene expression in cancer. Curr Pharm Des 10, 635-646.
4. Figueiredo-Pereira ME, Li Z, Jansen M, Rockwell P (2002). N-acetylcysteine and celecoxib lessen cadmium cytotoxicity which is associated with cyclooxygenase-2 up-regulation in mouse neuronal cells. J Biol Chem 277, 25283-25289. (Pubitemid 34951837)
5. Fujimori K, Kanaoka Y, Sakaguchi Y, Urade Y (2000). Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells. Roles of the Oct-1 element in the 5′-flanking region and the AP-2 element in the untranslated exon 1. J Biol Chem 275, 40511-40516. (Pubitemid 32064688)
6. Hayes JD, Flanagan JU, Jowsey IR (2005). Glutathione transferases. Annu Rev Pharmacol Toxicol 45, 51-88. (Pubitemid 40261798)
7. Helliwell RJ, Adams LF, Mitchell MD (2004). Prostaglandin synthases: recent developments and a novel hypothesis. Prostaglandins Leukot Essent Fatty Acids 70, 101-113. (Pubitemid 38141900)
8. Hirsch C, Gauss R, Horn SC, Neuber O, Sommer T (2009). The ubiquitylation machinery of the endoplasmic reticulum. Nature 458, 453-460.
9. Hoseki J, Ushioda R, Nagata K (2010). Mechanism and components of endoplasmic reticulum-associated degradation. J Biochem 147, 19-25.
10. Hurley JH, Lee S, Prag G (2006). Ubiquitin-binding domains. Biochem J 399, 361-372. (Pubitemid 44672627)
11. Kanaoka Y et al. (1997). Cloning and crystal structure of hematopoietic prostaglandin D synthase. Cell 90, 1085-1095. (Pubitemid 27408522)
12. Kanaoka Y, Fujimori K, Kikuno R, Sakaguchi Y, Urade Y, Hayaishi O (2000). Structure and chromosomal localization of human and mouse genes for hematopoietic prostaglandin D synthase. Conservation of the ancestral genomic structure of sigma-class glutathione S-transferase. Eur J Biochem 267, 3315-3322. (Pubitemid 30341160)
13. Kanaoka Y, Urade Y (2003). Hematopoietic prostaglandin D synthase. Prostaglandins Leukot Essent Fatty Acids 69, 163-167. (Pubitemid 36976171)
14. Kang YJ, Mbonye UR, DeLong CJ, Wada M, Smith WL (2007). Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res 46, 108-125. (Pubitemid 46661865)
15. Komander D (2009). The emerging complexity of protein ubiquitination. Biochem Soc Trans 37, 937-953.
16. Kuhlbrodt K, Mouysset J, Hoppe T (2005). Orchestra for assembly and fate of polyubiquitin chains. Essays Biochem 41, 1-14. (Pubitemid 41500967)
17. Leichner GS, Avner R, Harats D, Roitelman J (2009). Dislocation of HMG-CoA reductase and Insig-1, two polytopic endoplasmic reticulum proteins, en route to proteasomal degradation. Mol Biol Cell 20, 3330-3341.
18. Mbonye UR, Song I (2009). Posttranscriptional and posttranslational determinants of cyclooxygenase expression. BMB Rep 42, 552-560.
19. Mbonye UR, Wada M, Rieke CJ, Tang HY, Dewitt DL, Smith WL (2006). The 19-amino acid cassette of cyclooxygenase-2 mediates entry of the protein into the endoplasmic reticulum-associated degradation system. J Biol Chem 281, 35770-35778. (Pubitemid 46041308)
20. Mbonye UR, Yuan C, Harris CE, Sidhu RS, Song I, Arakawa T, Smith WL (2008). Two distinct pathways for cyclooxygenase-2 protein degradation. J Biol Chem 283, 8611-8623.
21. Mehnert M, Sommer T, Jarosch E (2010). ERAD ubiquitin ligases: multifunctional tools for protein quality control and waste disposal in the endoplasmic reticulum. Bioessays 32, 905-913.
22. Mevkh AT, Miroshnikov KA, Igumnova ND, Varfolomeev SD (1993). Prostaglandin H synthase. Inactivation of the enzyme in the course of catalysis is accompanied by fast and dramatic changes in protein structure. FEBS Lett 321, 205-208. (Pubitemid 23114078)
23. Miller J, Gordon C (2005). The regulation of proteasome degradation by multi-ubiquitin chain binding proteins. FEBS Lett 579, 3224-3230. (Pubitemid 40804667)
24. Mishra A, Godavarthi SK, Maheshwari M, Goswami A, Jana NR (2009). The ubiquitin ligase E6-AP is induced and recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of Hsp70-bound misfolded proteins. J Biol Chem 284, 10537-10545.
25. Mohri I, Aritake K, Taniguchi H, Sato Y, Kamauchi S, Nagata N, Maruyama T, Taniike M, Urade Y (2009). Inhibition of prostaglandin D synthase suppresses muscular necrosis. Am J Pathol 174, 1735-1744.
26. Mohri I, Eguchi N, Suzuki K, Urade Y, Taniike M (2003). Hematopoietic prostaglandin D synthase is expressed in microglia in the developing postnatal mouse brain. Glia 42, 263-274. (Pubitemid 36538339)
27. Mohri I et al. (2006). Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J Neurosci 26, 4383-4393. (Pubitemid 44315397)
28. Moraitis AN, Giguere V (2003). The co-repressor hairless protects RORá orphan nuclear receptor from proteasome-mediated degradation. J Biol Chem 278, 52511-52518. (Pubitemid 38035845)
29. Nakata M, Maruyama I, Yada T (2005). Leptin potentiates ADP-induced [Ca2+]i increase via JAK2 and tyrosine kinases in a megakaryoblast cell line. Diabetes Res Clin Pract 70, 209-216. (Pubitemid 41539781)
30. Park JM et al. (2007). Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+mice. Cancer Res 67, 881-889.
31. Rouzer CA, Marnett LJ (2003). Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases. Chem Rev 103, 2239-2304.
32. Shimura C, Satoh T, Igawa K, Aritake K, Urade Y, Nakamura M, Yokozeki H (2010). Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin. Am J Pathol 176, 227-237.
33. Smith WL, DeWitt DL, Garavito RM (2000). Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69, 145-182.
34. Smith WL, Song I (2002). The enzymology of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins Other Lipid Mediat 68-69, 115-128. (Pubitemid 35247391)
35. Tanaka H et al. (2011). Improvement in the quality of hematopoietic prostaglandin D synthase crystals in a microgravity environment. J Synchrotron Radiat 18, 88-91.
36. Tanaka K, Ogawa K, Sugamura K, Nakamura M, Takano S, Nagata K (2000). Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. J Immunol 164, 2277-2280. (Pubitemid 30115452)
37. Thomson AM, Meyer DJ, Hayes JD (1998). Sequence, catalytic properties and expression of chicken glutathione-dependent prostaglandin D2 synthase, a novel class Sigma glutathione S-transferase. Biochem J 333, 317-325.
38. Ueno N, Murakami M, Tanioka T, Fujimori K, Tanabe T, Urade Y, Kudo I (2001). Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2. J Biol Chem 276, 34918-34927.
39. Ueno N, Takegoshi Y, Kamei D, Kudo I, Murakami M (2005). Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem Biophys Res Commun 338, 70-76. (Pubitemid 41540538)
40. Urade Y, Hayaishi O (2000a). Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim Biophys Acta 1482, 259-271.
41. Urade Y, Hayaishi O (2000b). Prostaglandin D synthase: structure and function. Vitam Horm 58, 89-120.
42. Urade Y, Ujihara M, Horiguchi Y, Ikai K, Hayaishi O (1989). The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. J Immunol 143, 2982-2989. (Pubitemid 19281848)
43. Wada M, Saunders TL, Morrow J, Milne GL, Walker KP, Dey SK, Brock TG, Opp MR, Aronoff DM, Smith WL (2009). Two pathways for cyclooxygenase-2 protein degradation in vivo. J Biol Chem 284, 30742-30753.
44. Welchman RL, Gordon C, Mayer RJ (2005). Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol 6, 599-609. (Pubitemid 41081264)
45. Wickliffe K, Williamson A, Jin L, Rape M (2009). The multiple layers of ubiquitin-dependent cell cycle control. Chem Rev 109, 1537-1548.
46. Wojcikiewicz RJ, Pearce MM, Sliter DA, Wang Y (2009). When worlds collide: IP(3) receptors and the ERAD pathway. Cell Calcium 46, 147-153.
47. Yamamoto M et al. (2009). Expression and characterization of PGD2 receptors in chronic rhinosinusitis: modulation of DP and CRTH2 by PGD2. Int Arch Allergy Immunol 148, 127-136.